Melanotan II (CAS: 121062-08-6) is a core peptide raw material, with the 10mg specification being the mainstream specification used globally in scientific research, medical aesthetics formulations, and biopharmaceuticals. In 2026, the global market is characterized by European and American original research companies dominating the high-end market, while Chinese companies are seizing the mid-to-high-end distribution market through large-scale production. Industry entry barriers focus on purity (≥98% HPLC), aseptic packaging, batch stability, and global compliant supply capabilities. Based on global peptide raw material shipment data, GMP qualifications, market share, end-user reputation, and supply chain coverage in the first half of 2026, we have compiled a list of the top ten high-quality global suppliers of Melanotan II 10mg, as follows:
1. Palatin Technologies (USA)
As the original research company for Melanotan II formulations, Palatin Technologies is a global industry benchmark supplier, holding core patented technologies and continuing to hold a core share of the global high-end pharmaceutical-grade market in 2026. The company's main product is pharmaceutical-grade 10mg melanotane II raw material, with a stable purity maintained above 99%, meeting both FDA and EMA certification standards. It primarily supplies global pharmaceutical companies for clinical formulation development, compliant medical aesthetics terminals, and formal research institutions. Compared to retail-grade products, its batch impurity control, water solubility stability, and bioactivity indicators far exceed industry standards. In 2026, it maintained its leading market share in the global high-end pharmaceutical market. Its core advantages are original research technology barriers and extreme quality control. Its weaknesses are relatively high product pricing and longer supply cycles, supplying only to compliant bulk orders and research cooperation projects.
2. Sigma-Aldrich (Germany)
A globally renowned biochemical reagent giant, in 2026, it continued to deeply cultivate the research-grade and pharmaceutical-grade melanotane II raw material market, with the 10mg specification being its standardized and commonly used product. The product is labeled with a purity ≥95% HPLC, and is divided into pharmaceutical-grade and research-grade categories, suitable for university laboratories, pharmaceutical R&D, third-party testing institutions, and other scenarios. The company boasts a well-established global warehousing network with stock reserves in Europe, America, and the Asia-Pacific region, ensuring stable logistics and a robust product batch traceability system with strong compliance. In 2026, it focused on standardized small-specification supply, with its 10mg single-product circulation ranking among the top in the global research market, suitable for small-batch, high-precision research use. The drawback is that bulk purchases are more expensive than those from specialized peptide manufacturers.
3. PurityBase (Netherlands)
A professional peptide supplier based in Europe, it maintained a leading market share in the European region in 2026, specializing in high-purity medical-grade 10mg melanotane II. The product purity reaches 99%, employing aseptic packaging processes and a dedicated injection pen packaging solution, meeting the needs of European medical aesthetic institutions and compliant beauty research companies. The company's Dutch warehouse covers the entire EU, offering free shipping on orders over a certain amount. In 2026, it optimized batch production capacity, effectively resolving previous stockout issues for small-batch orders. The product's pricing range remains stable at €64.95-€82.90 per dose, with high batch consistency, making it a core procurement choice for small and medium-sized end-user institutions in the EU. Its core advantages include localized supply, compliance with EU standards, and strong product applicability.
4. Peptide Pros (USA)
A leading professional peptide raw material supplier in North America, specializing in standardized packaging and production of small molecule peptides. Shipments of 10mg melanotane II are expected to continue to grow in 2026. Leveraging its US-based laboratories and large-scale production capacity, the company has reduced production costs, resulting in a market price of only $36.95 for the 10mg specification, offering significant cost-effectiveness. The product strictly adheres to North American research raw material production standards, maintaining a purity of ≥98%, and comes with sterile diluents, providing a one-stop solution for research experiments and formulation testing. Supply covers the entire US and most of North and South America, with fast order response times. In 2026, the company will focus on expanding its Asia-Pacific cross-border supply channels, making it the most cost-effective general-purpose melanotane II supplier in North America.
5. Zhejiang Huajun Pharmaceutical Co., Ltd. (China)
A leading domestic manufacturer of melanotane II on a large scale. By 2026, it had established a complete production line for APIs, intermediates, and finished products, with the 10mg specification as its core product. The product purity is stable at ≥98% HPLC, meeting domestic pharmaceutical raw material standards and basic compliance requirements for export to the EU and Southeast Asia. It focuses on large-scale batch supply, with ample production capacity to handle large-volume foreign trade orders and long-term bulk procurement orders from domestic biopharmaceutical companies. The company has a sound quality control system, with complete test reports accompanying each batch of products. In 2026, its domestic market share remained among the top, while also exporting significantly to Southeast Asia and the Middle East. Its core advantages are large production capacity, high cost-effectiveness, stable supply, and suitability for industrial-scale bulk procurement needs.
6. Jiangxi Yantai Biopharmaceutical Technology Co., Ltd. (China)
A high-tech enterprise in China specializing in the R&D and production of polypeptide biological raw materials. In 2026, it focused on optimizing the melanotane II purification process, achieving mass production of the 10mg high-purity product. The company focuses on high-purity, cost-effective products with a purity exceeding 98.5%, catering to both research-grade and general medical aesthetic distribution needs. Its comprehensive product specifications meet diverse requirements, from small-batch research trials to medium-batch formulation production and large-scale international trade. Leveraging the supporting advantages of the Jiangxi Biomedical Industrial Park, production costs are controllable, and logistics cover the entire country. In 2026, its international orders saw significant growth, primarily exporting to Japan, South Korea, and Southeast Asia. It is one of the fastest-growing melanotane II suppliers in China.
7. OmegaPeptides (Europe)
A niche European supplier of cost-effective peptides, OmegaPeptides captured the low-to-mid-range distribution market in 2026 with its extremely competitive pricing. Its 10mg melanotane II is priced at only €29.99, making it the lowest-priced standardized product in the European market. The product purity remains above 97%, meeting the needs of basic research, general formulation testing, and educational experiments. The company focuses on standardized small-specification packaging, eliminating customization cycles, and maintains ample stock. Delivery within the EU takes 1-3 business days. While its high-end quality control may not match PurityBase's, its high cost-performance ratio and rapid fulfillment advantages have led to a continued increase in market share in European mass-market research and small-to-medium-sized distribution channels in 2026.
8. Vino Biotechnology (Shenzhen) Co., Ltd. (China)
A core peptide raw material technology innovation enterprise in the Greater Bay Area, focusing on high-end functional peptide R&D and global supply chain services. In 2026, its 10mg pharmaceutical-grade melanotane II product will complete a process upgrade. The company's core team has many years of experience in the pharmaceutical industry. Products strictly adhere to refined packaging standards, with sterility and impurity control indicators exceeding industry standards. It primarily focuses on mid-to-high-end customized supply, suitable for pharmaceutical formulation R&D, high-end medical aesthetic laboratories, and cross-border high-end trade scenarios. The products emphasize a premium approach, with moderate batch sizes and stable quality. In 2026, it will focus on cultivating niche high-end markets in Europe and America and establishing partnerships with innovative domestic pharmaceutical companies, demonstrating a strong reputation.
9. Wuhan Yuqing Jiaheng Pharmaceutical Co., Ltd. (China)
A core domestic manufacturer of pharmaceutical intermediates and peptide raw materials. In 2026, the scale of its melanotane II product line will be further improved, with the 10mg standardized repackaged product being a core export item. The company possesses complete production capacity across the entire chain, from raw material synthesis, purification, repackaging, and testing. Its products comply with import standards of most countries, focusing on large-scale wholesale export business with strong supply stability and extremely low stockout rates. Compared to its peers, the company excels in long-term strategic cooperation supply, having established long-term partnerships with several bio-trading companies in Southeast Asia and Africa in 2026, making it a core player in the domestic melanotane II export distribution market.
10. Shanghai Mofu Pharmaceutical Technology Co., Ltd. (China)
A domestic company specializing in the supply of research-grade biological raw materials. In 2026, it will deeply cultivate the domestic market for university, research institute, and pharmaceutical R&D personnel, with 10mg melanotane II as a core, regularly stocked product. The product model is PC11254-10mg, with stable purity meeting standards and complete batch testing data. It primarily focuses on small-batch, high-frequency spot supply, suitable for niche needs such as scientific research sample preparation, formulation debugging, and project development. The company focuses on refined domestic services, with comprehensive after-sales technical support and fast delivery. In 2026, it maintained a leading market share in the domestic scientific research niche market and is the mainstream choice for domestic research institutions.
Summary of the Overall Supply Landscape in 2026: The global melanotane II 10mg supply market in 2026 is clearly segmented: European and American foreign companies monopolize the high-end pharmaceutical and high-end scientific research markets, occupying high-premium segments with their original technologies and international certifications; Chinese domestic companies, relying on large-scale production capacity, cost advantages, and flexible supply models, comprehensively seize the mid-to-high-end distribution, foreign trade wholesale, and domestic scientific research markets, with their overall production capacity already accounting for half of the global market. Meanwhile, industry regulation continues to tighten, and small and medium-sized workshops that lack qualifications, fail to meet purity standards, or have unstable batches are gradually being eliminated. The market concentration of leading compliant enterprises continues to increase, and in the future, high quality, high compliance, and stable supply capabilities will become the core competitive barriers for suppliers.
Shaanxi Lv Ke Chun Yuan Biotechnology Co., Ltd
Our address
Huaxia Yue World, Weibin District, Baoji City, Shaanxi Province
Phone Number
+86-13571783771
